• Text Resize A A A
  • Print Print
  • Share Share Share Share

Forty-Fifth ACBTSA Meeting: November 13-14, 2014

November 13, 2014 - November 14, 2014

Double Tree Hotel
300 Army Navy Dr
Arlington, VA 22202

Agenda

Thursday, November, 13, 2014

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to Public
08:00
(10 min)
Call to Order Jay Menitove, MD
Committee Chair
08:10
(5 min)
Roll Call James Berger
Executive Secretary

Committee Business

Time Agenda Item Presenter
08:15
(20 min)
Principal Deputy Assistant Secretary for Health’s Charge to the Committee  Wanda Jones, DrPH
HHS Principal Deputy Assistant Secretary for Health

Blood Donor Policy for Men who have Sex with Men

Time Agenda Item Presenter
08:35
(15 min)
Introduction to MSM Blood Donor Deferral Policy Discussion James Berger
Executive Secretary
08:50
(20 min)
Origin, Evolution, and Effectiveness of MSM Blood Donor Deferral Policy Alan E. Williams, Ph.D.
Associate Director, Office of Blood
Research and Review
CBER, FDA
09:10
(20 min)
Current Epidemiology of HIV in the US Amy Lansky, PhD, MPH
Deputy Director for Surveillance, Epidemiology, and Laboratory Sciences
Division of HIV/AIDS Prevention, CDC
09:30
(40 min)
Retrovirus Epidemiology Donor Study-II (REDS-II) TTI Marker Prevalence and Risk Factor Study Simone Glynn, MD, MSc, MPH
Branch Chief Blood Epidemiology and Clinical
Therapeutics Branch
National Heart, Blood, and Lung Institute
10:10 Break • 10 min  
10:20
(40 min)
Results of the Recipient Epidemiology and Donor Evaluation Study – III (REDS-III) Blood Donation Rules Opinion Study (Blood DROPS) Brian Custer, PhD, MPH
Associate Investigator
Epidemiology and Health Research
Policy Blood Systems Research Institute
11:00
(20 min)
Cognitive Interviewing Evaluation of the UDHQ: Results and Next Steps Kristen Miller, Ph.D. and Stephanie Willson, Ph.D.
National Center for Health Statistics
11:20
(20 min)
The Australia MSM Blood Donor Deferral Experience Richard Benjamin MD, PhD, FRCPath
Chief Medical Director
American Red Cross
11:40
(20 min)
Discussion of MSM Blood Policy Deferral Options Harvey Alter, MD
Chief, Clinical Studies
Associate Director of Research
Department of Transfusion Medicine, NIH
12:00
(45 min)
Open Public Hearing (all sessions/ considerations)  
12:45 Lunch Break • 45 min  
01:30
(2 hrs)
Committee Questions, Discussion, and Recommendations  
03:30 Adjournment Jay Menitove, MD
Committee Chair

Friday, November, 14, 2014

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to Public
08:00
(5 min)
Call to Order Jay Menitove, MD
Committee Chair
08:05
(10 min)
Roll Call James Berger
Executive Secretary

Advisory Committee Update

Time Agenda Item Presenter
08:15
(15 min)
Subcommittee Update: Informed Consent in Transfusion and Transplantation  Jim Bowman, MD
Medical Director
Division of Transplantation
HHS/HRSA

Hemoglobin S Testing in Blood Donors

Time Agenda Item Presenter
08:30
(30 min)
Hemoglobin S Testing in Blood Donors  Orieji Illoh, MD
Deputy Director
Division of Blood Components and Devices
FDA/CBER/OBRR
09:00
(30 min)
Presidential Commission for the Study of Bioethical Issues: Ethical Implications of Incidental Findings Lisa M. Lee, PhD, MS
Executive Director
Presidential Commission for the Study of Bioethical Issues
09:30
(30 min)
Ethical Issues in Sickle Screening Norman Fost, MD, MPH
Professor Emeritus Departments of Pediatrics and Medical History & Bioethics
University of Wisconsin School of Medicine and Public Health
10:00
(30 min)
Returning hematoglobinopathy results to blood donors: ethical considerations Steven Joffe, MD, MPH
Emanuel and Robert Hart Associate
Professor
Vice-Chair, Department of Medical Ethics and Health Policy
University of Pennsylvania Perelman School of Medicine
10:30 Break • 10 min  
10:40
(20 min)
Sickle Cell Testing in Independent Blood Centers Louis M. Katz, MD
Chief Medical Officer
America’s Blood Center
11:00
(30 min)
Blood Center Perspective Yelena Ginzburg, MD
Medical Director, Medical Programs and Services
New York Blood Center
11:30
(30 min)
Sourcing and Transfusing RBC for Selected Populations and Responding to Donors with Positive Sickle Screening Naomi L. C. Luban, M.D.
Director, Transfusion Medicine, The Edward J. Miller Jr. Blood Donor Center
Vice Chair for Academic Affairs, Children’s National Medical Center
Professor, Pediatrics and Pathology, The George Washington University School of Medicine
12:00
(15 min)
Patient and Family Perspective on Hemoglobin S testing Larry Allen
Executive Secretary, Committee of Ten Thousand
12:15 Lunch Break • 45 min  
01:00
(25 min)
Open Public Hearing (all sessions/ considerations)  

Emerging Infectious Diseases

Time Agenda Item Presenter
01:25
(25 min)
Public Health Perspective on a Progressively Emerging Threat Alfred DeMaria, MD
Medical Director, Bureau of Infectious Disease
Massachusetts Department of Public Health
01:50
(25 min)
Transfusion Transmitted Babesiosis: Perspectives from the NYBC Experience Beth Shaz, MD
Chief Medical Officer
New York Blood Center
02:15
(25 min)
Ethical Issues for selective Infectious Disease Testing Richard Benjamin MD, PhD, FRCPath
Chief Medical Director
American Red Cross
02:40 
(2 hrs)
Committee Questions, Discussion, and Recommendations  
04:40 Adjournment Jay Menitove, MD
Committee Chair
Back to Top